title: Validity of conners' adult attention-deficit/hyperactivity disorder rating Scale-investigator rated: screening version in patients from within and outside of Europe.
abstract: In adult patients with attention-deficit/hyperactivity disorder from within and outside of Europe, Conners' Adult Attention-Deficit/Hyperactivity Disorder (ADHD) Rating Scale-Investigator Rated: Screening Version showed good internal consistency (Cronbach's α=0.930 and 0.938, respectively) and convergent validity with the Clinical (Pearson's correlation coefficients: 0.65-0.82, P<0.001) Global Impression-ADHD-Severity scale over 12 weeks of pharmacological treatment.
authors: PsyQ, Carel Reinierszkade 197, 2593h Den Haag, The Netherlands.
authors: J J
authors: JJ
authors: Sandra Kooij
authors: C
authors: C
authors: Keith Conners
authors: Taro
authors: T
authors: Goto
authors: Yoko
authors: Y
authors: Tanaka
authors: David
authors: D
authors: Williams
authors: Albert J
authors: AJ
authors: Allen
authors: Alexandra N
authors: AN
authors: Heinloth
authors: Himanshu P
authors: HP
authors: Upadhyaya
mesh_terms: D000293:Adolescent; D000328:Adult; D001118:Argentina; D000069445:Atomoxetine Hydrochloride; D001289:Attention Deficit Disorder with Hyperactivity / Q000175:diagnosis* / Q000188:drug therapy; D005060:Europe; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009656:North America; D011437:Propylamines / Q000627:therapeutic use; D011569:Psychiatric Status Rating Scales; D015203:Reproducibility of Results; D012426:Russia
chemical_list: D011437:Propylamines; D000069445:Atomoxetine Hydrochloride